Thousands to benefit as new medicines added to Pharmaceutical Benefits Scheme

Google+ Pinterest LinkedIn Tumblr +

Source: ABC News

A number of new medicines to treat cancer, diabetes, multiple sclerosis and other diseases have been added to the Pharmaceutical Benefits Scheme (PBS).


Federal Health Minister Peter Dutton says the latest round of PBS changes will see around another 50 new and amended medicines and technologies subsidised.

He says around 230,000 people are expected to now receive medicines they might otherwise not have been able to afford.

Among the new drugs is Dabrafenib, sold as Rafinlar, which is the first melanoma medicine that targets a genetic mutation present in about half of all melanoma cases.

Another new medicine, Sunitinib (Sutent), for pancreatic cancer, increases survival rates of patients who cannot undergo surgery.

And denosumab (Prolia), available on the PBS for the treatment of osteoporosis in women, is being extended to benefit around 5,700 men…READ MORE

Follow this link to see all New listings for the PBS announced on 28 October 2013




About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Comments are closed.